Adenocarcinoma in Barrett's esophagus.
Adenocarcinoma arising in association with the columnar-lined esophagus is now recognized with increasing frequency. The incidence of malignant degeneration in Barrett's esophagus, its etiology, and pathogenesis are all issues of ongoing debate. The role of gastroesophageal reflux in driving the malignant change remains unproven. Surgical resection is the treatment of choice; however, prognosis is generally poor. Surveillance of patients with non-malignant Barrett's esophagus permits detection of early lesions where resection results in excellent long-term survival.
Altorki
N K
NK
Division of Cardiothoracic Surgery, New York Hospital-Cornell University Medical College, New York.
Skinner
D B
DB
D000230:Adenocarcinoma / Q000453:epidemiology* / Q000209:etiology / Q000601:surgery; D001471:Barrett Esophagus / Q000453:epidemiology* / Q000601:surgery; D002471:Cell Transformation, Neoplastic; D004938:Esophageal Neoplasms / Q000453:epidemiology* / Q000209:etiology / Q000601:surgery; D006801:Humans; D015994:Incidence; D008297:Male; D011230:Precancerous Conditions / Q000453:epidemiology* / Q000601:surgery; D015995:Prevalence